Previous Close | 5.31 |
Open | 5.22 |
Bid | 5.33 x 100 |
Ask | 5.51 x 100 |
Day's Range | 5.20 - 5.50 |
52 Week Range | 4.05 - 9.94 |
Volume | |
Avg. Volume | 53,195 |
Market Cap | 103.405M |
Beta (5Y Monthly) | -0.27 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.98 |
Earnings Date | May 09, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 24, 2022 |
1y Target Est | 21.00 |
ProPhase Labs (PRPH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
GARDEN CITY, NY, May 02, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH), announced today that they will be presenting first quarter 2024 financial results on a virtual conference call hosted by Renmark Financial on May 9, 2024 at 11:00 am EDT. A press release detailing these results will be issued prior to the virtual conference call. ProPhase Labs Inc. welcomes stakeholders, investors, and other individual followers to register and attend this live event. Investors interested in par
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet MicroCap presents the Planet MicroCap Showcase: VEGAS taking place on April 30 - May 2, 2024, where 96 MicroCap public and private companies will be presenting at the Paris Hotel & Casino in Las ...